Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
11 Ergebnisse für "acute" unter Roche Glycart AG
Test Elecsys® pour la troponine T hypersensible
... concentrations below the limit of detection to exclude acute myocardial infarction: a prospective evaluation ... . Maria Rubini Gimenez, Rebeca Hoeller, Tobias Reichlin and al. Rapid rule out of acute myocardial ... concentrations below the limit of detection to exclude acute myocardial infarction: a prospective evaluation ... . Maria Rubini Gimenez, Rebeca Hoeller, Tobias Reichlin and al. Rapid rule out of acute myocardial ...
Elecsys® NT-proBNP
... acute and chronic heart failure. Eur J heart Fail. 18, 891-975 Yancy CW, Jessup M, Bozkurt B,and al ... . NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an ... . Anker and al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure ... diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
